Dynavax Technologies Fills New President Position
Dr Martin brings with him 20 years of experience in the biotechnology industry. Before joining Dynavax Technologies, Dr Martin served as a president of Humabs. Prior to that
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.
Upp Technology’s software selected from the suite includes IRMS|EM Emergency Management, IRMS|WM Warehouse Management and IRMS|BI Business Intelligence to provide the BSPS with real-time visibility, enhanced accuracy and
The collaboration will use Marina’s patented Trp Cage phage display library and Dr Laakkonen’s expertise with phage display libraries and experience in the evaluation of peptides for preferential